Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Many Locations, Korea, Republic of Clinical Trials

A listing of Many Locations, Korea, Republic of clinical trials actively recruiting patients volunteers.

RESULTS

Found (4) clinical trials

Pomalidomide-Cyclophosphamide-Dexamethasone (PCD) Versus Pomalidomide-Dexamethasone (PD) in Relapse or Refractory Myeloma

In this study, we will prospectively enrol 120 Asian patients with relapsed myeloma after prior treatment with bortezomib and lenalidomide, and randomised them between PCD and PD (60 in each arms). Centers in Singapore, Korea, Taiwan, and Hong Kong will participate in this study. Pomalidomide is a new immunomodulatory drug, ...

Phase

0.0 miles

Learn More »

Carfilzomib Thalidomide and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma

All patients will continue treatment for 18 cycles (12 induction cycles, 6 maintenance cycles) unless development of adverse events that require early cessation of treatment. Patients will be followed up for progression and survival until 1 year following the completion of the last patient's final cycle of induction therapy. Proteasome ...

Phase

0.0 miles

Learn More »

A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)

Participants considered an adult according to local regulation at the time of obtaining informed consent may participate in the study.

Phase

0.0 miles

Learn More »

Daratumumab Thalidomide and Dexamethasone in Relapse and/or Refractory Myeloma

Daratumumab is a humanized antibody against CD38 which is expressed on myeloma cells. Daratumumab exhibited single agent activity in myeloma and is a promising new treatment. Recently, 2 phase 1 / 2 studies establishes the dosing regimen for Daratumumab and impressive single agent activity of about 30% response rates in ...

Phase

0.0 miles

Learn More »